111 (NASDAQ:YI) Director Yang Luke Chen Sells 44,000 Shares of Stock

111, Inc. Sponsored ADR (NASDAQ:YI) Director Yang Luke Chen sold 44,000 shares of the stock in a transaction on Monday, June 15th. The stock was sold at an average price of $0.23, for a total transaction of $10,120.00. Following the sale, the director owned 495,462 shares of the company’s stock, valued at approximately $113,956.26. This represents a 8.16% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Yang Luke Chen also recently made the following trade(s):

• On Friday, June 12th, Yang Luke Chen sold 49,920 shares of 111 stock. The stock was sold at an average price of $0.23, for a total transaction of $11,481.60.
• On Wednesday, May 27th, Yang Luke Chen sold 3,400 shares of 111 stock. The stock was sold at an average price of $0.25, for a total value of $850.00.
• On Tuesday, May 26th, Yang Luke Chen sold 1,440 shares of 111 stock. The stock was sold at an average price of $0.27, for a total value of $388.80.

111 Trading Down 2.6%

111 stock opened at $4.45 on Wednesday. 111, Inc. Sponsored ADR has a twelve month low of $2.48 and a twelve month high of $11.17. The stock has a market capitalization of $39.09 million, a price-to-earnings ratio of -3.18 and a beta of 0.60. The stock has a 50 day moving average of $5.84 and a two-hundred day moving average of $5.67.

Analyst Ratings Changes

Separately, Weiss Ratings cut 111 from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, June 4th. One analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has a consensus rating of “Sell”.

111 Company Profile

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.